1. May 24, 2022

    Coronavirus: the Belgian guideline for the management of clinical trials during the coronavirus pandemic no longer applies

    Due to the ending of the epidemiological emergency situation on 10 March 2022, the Belgian guideline to assist sponsors in the management of clinical trials during the coronavirus pandemic no longer applies. From now on, the rules in force will be applied and any deviation must be requested by providing a clear description of the situation. 

    Source: FAMHP

    Read more

  2. May 18, 2022

    New antimicrobial drugs available in Belgium: Colistineb, Zerbaxa, Broxil and Rukobia. Important for patients and for the fight against antimicrobial resistance.

    De beschikbaarheid van geschikte antimicrobiële middelen zorgt ervoor dat artsen meer mogelijkheden hebben om de beste behandeling te voorzien voor hun patiënten. Het is ook belangrijk in de strijd tegen antimicrobiële resistentie. Colistineb, Zerbaxa, Broxil en Rukobia zijn  antimicrobiële geneesmiddelen die recent beschikbaar werden in België.

    La disponibilité des médicaments antimicrobiens appropriés donne aux médecins davantage de possibilités de fournir le meilleur traitement à leurs patients. Elle est également importante dans la lutte contre la résistance aux antimicrobiens. Colistineb, Zerbaxa, Broxil et Rukobia sont des médicaments antimicrobiens qui ont récemment été mis sur le marché en Belgique.

    Source: FAMHP

    Read more

  3. May 17, 2022

    Call for tender by the European Commission: reservation of manufacturing capacities and priority right to manufacture vaccines

    The European Commission has launched a call for tender to conclude single (consortium) framework contracts to reserve manufacturing capacities and obtain a priority right to manufacture vaccines in case of a future public health emergency. The project is called EU FAB.

    Source: FAMHP

    Read more

  4. May 16, 2022

    PRAC May 2022 – Discussion regarding a direct healthcare professional communication (DHPC) containing important information for Defitelio

    During its April 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) discussed a direct healthcare professional communication (DHPC) containing important information for Defitelio. 

    Source: FAMHP

    Read more

  5. May 12, 2022

    Online training: Managing and reporting serious breaches of the EU Clinical Trial Regulation

    New Online Training from Brookwood Global, on demand.
    Do it anywhere! Log in at any time 24/7, 365 days a year.

    Read more

  6. May 6, 2022

    IFAPP Today newsletter - May 2022

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of May 2022, in which Healixia is featured!

    Read more

  7. May 5, 2022

    EU announces “A European Health Data Space for people and science” and puts patients in control of their healthdata

    Today, the European Commission launched the European Health Data Space (EHDS), one of the central building blocks of a strong European Health Union. The EHDS will help the EU to achieve a quantum leap forward in the way healthcare is provided to people across Europe.

    Read more

  8. April 29, 2022

    Coronavirus: monthly update of COVID-19 vaccines 28 April 2022

    Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 28 april 2022

    Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 28 avril 2022

    Source: FAMHP

    Read more

  9. April 26, 2022

    Impact of war in Ukraine on clinical trials

    The current war in Ukraine has had a huge impact on clinical trials in Ukraine, Russia and Belarus. Due to the war, a large number of patients in these countries participating in clinical trials are no longer able to participate. There are also problems with the supply of medicinal products and other supplies for conducting clinical trials.

    Source: FAMHP

    Read more

  10. April 25, 2022

    NVFG Medical Affairs Day on May 12th, 2022

    NVFG (Nederlandse Vereniging van Farmaceutisch Geneeskunde) organises a full day dedicated to Medical Affairs (Veenendaal, May 12th, from 9 to 18 hrs) under the umbrella “De patiënt centraal” (the symposium will be in Dutch). 

    Read more